Investors

Our Investors

To achieve our ambitious strategy to become a leading biotech company in the development of single-strain keystone biotherapies, we are open to welcome new investors.

Established in 2010, YSOPIA Bioscience has already raised €22.7M.

> Discover our pipeline

Key facts:

We are backed by renowned and valuable investors.

Seventure Partners / Health For Life Capital, Europe’s leading microbiome innovation investment fund, is our historic lead investor.

Three family offices have also backed YSOPIA Bioscience, as well as public investors, including the Nouvelle Aquitaine region. We also received support from BPI France.

Want to talk to our CEO?

Microbiome & us
News
Mar 29, 2021
Lancement de l’Alliance Promotion Microbiote | L’Alliance Promotion Microbiote est lancée : fruit de l’union...
> more
Mar 4, 2021
YSOPIA Bioscience Announces the First Positive Safety Results of its CAUSALITY Study in Obesity and Associated Metabolic...
> more
Press / Media
Mar 4, 2021
Read the full article    
> more
Mar 4, 2021
15h Biotech Express Jeudi : Abivax, Ysopia Bioscience, HealthTech Innovation Days, Conférence White Fund Par Rédaction...
> more
Publications
Apr 22, 2020
Keystone gut bacteria are the foundation of the whole microbial ecosystem because they provide very specific metabolic...
> more
Dec 6, 2019
The term “microbiome” refers to the collection of microorganisms (or microbiota) – including bacteria, viruses and...
> more
now on twitter
YSOPIA Bioscience

Stress, anxiety, or even fear can cause digestive issues is because our gut and brain actually communicate with eac… t.co/uxG5H5nLY0

YSOPIA Bioscience © 2021 - all rights reserved terms and conditions